Compare IMNM & BWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMNM | BWIN |
|---|---|---|
| Founded | 2006 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 3.0B |
| IPO Year | 2020 | 2019 |
| Metric | IMNM | BWIN |
|---|---|---|
| Price | $23.85 | $32.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 7 |
| Target Price | ★ $32.80 | $30.43 |
| AVG Volume (30 Days) | 884.8K | ★ 2.2M |
| Earning Date | 05-08-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.40 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $6,941,000.00 | ★ $1,504,884,000.00 |
| Revenue This Year | N/A | $36.36 |
| Revenue Next Year | $1,127.34 | $10.82 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 8.34 |
| 52 Week Low | $8.93 | $15.88 |
| 52 Week High | $30.06 | $32.59 |
| Indicator | IMNM | BWIN |
|---|---|---|
| Relative Strength Index (RSI) | 35.85 | 62.04 |
| Support Level | $23.67 | $25.11 |
| Resistance Level | $25.07 | N/A |
| Average True Range (ATR) | 1.00 | 1.06 |
| MACD | -0.59 | -0.02 |
| Stochastic Oscillator | 6.86 | 93.86 |
Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.
The Baldwin Insurance Group Inc is an insurance distribution company operating in the United States. The company provides commercial risk management, employee benefits, private risk management, and personal insurance solutions. It operates through three segments: Insurance Advisory Solutions, which focuses on commercial risk management and employee benefits; Underwriting, Capacity & Technology Solutions, which includes managing general agency operations, reinsurance brokerage, captive management, and technology-enabled insurance products; and Mainstreet Insurance Solutions, which offers personal, commercial, and life and health insurance products through community-based distribution channels.